R. Rajtar-Salwa

发表

Prevalence of familial hypercholesterolemia in patients with acute coronary syndromes.

D. Dudek, A. Dziewierz, W. Zasada, 2019, Kardiologia polska.

Predictors of Coronary and Carotid Atherosclerosis in Patients with Severe Degenerative Aortic Stenosis

D. Sorysz, D. Dudek, T. Rakowski, 2013, International journal of medical sciences.

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry

M. Wełnicki, J. Bednarski, M. Gawałko, 2021, Journal of clinical medicine.

Assessment of the implementation level of the guidelines for secondary prevention of cardiovascular disease in everyday clinical practice.

M. Hołda, A. Krawczyk-Ożóg, D. Dudek, 2021, Kardiologia polska.

Mavacamten - a new disease-specific option for pharmacological treatment of symptomatic patients with hypertrophic cardiomyopathy.

I. Olivotto, W. Wojakowski, G. Smołka, 2021, Kardiologia polska.

Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy

A. Dziewierz, P. Petkow-Dimitrow, R. Rajtar-Salwa, 2018, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund

A. Krawczyk-Ożóg, Beata Bobrowska, S. Bartuś, 2022, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Hypertrophic cardiomyopathy – symptomatic atrial fibrillation in a patient at high risk of sudden cardiac death (RCD code: V-2A.2)

M. Jastrzębski, P. Petkow-Dimitrow, R. Rajtar-Salwa, 2019, Journal of Rare Cardiovascular Diseases.

Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study

M. Wełnicki, J. Bednarski, B. Wożakowska-Kapłon, 2021, Journal of clinical medicine.

Pharmacotherapy of aortic stenosis-success or failure?

P. Dimitrow, R. Rajtar-Salwa, Marek Jawień, 2012, Current pharmaceutical biotechnology.

Positron emission tomography for myocardial viability assessment before myocardial revascularization in a patient with extremely impaired left ventricular systolic function – advanced diagnosis and therapy in heart failure

A. Krawczyk-Ożóg, D. Dudek, Beata Bobrowska, 2017, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry

M. Wełnicki, P. Krzesiński, Ł. Kuźma, 2022, International journal of environmental research and public health.

Effectiveness and safety of PCSK9 inhibitor therapy in patients with familial hypercholesterolemia within a therapeutic program in Poland: Preliminary multicenter data

M. Małecki, T. Zdrojewski, M. Gruchała, 2022, Cardiology journal.

Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort

M. Wełnicki, A. Lubas, J. Bednarski, 2022, International journal of environmental research and public health.

Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment

P. Dimitrow, R. Rajtar-Salwa, 2016, BioMed research international.

Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy

T. Tokarek, P. Dimitrow, R. Rajtar-Salwa, 2020, Disease markers.

Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014)

P. Dimitrow, R. Rajtar-Salwa, Rafał Hładij, 2017, Cardiovascular Ultrasound.

Reversed Septal Curvature Predicts Sudden Death in Hypertrophic Cardiomyopathy in Earlier Study.

P. Dimitrow, R. Rajtar-Salwa, 2020, Journal of the American College of Cardiology.

The diagnostic role of cardiac magnetic resonance used “first and last time in life” in a patient with a suspected dilated phase of hypertrophic cardiomyopathy

A. Dziewierz, P. Petkow-Dimitrow, R. Rajtar-Salwa, 2017, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Pol-tako - the first, nationwide Polish multicenter analysis of patients with takotsubo syndrome.

P. Ponikowski, Milosz Marona, G. Opolski, 2021, Kardiologia polska.

Ablation of incessant supraventricular tachycardia in pregnancy (RCD code: VIII-V-3A.O)

M. Jastrzębski, D. Czarnecka, R. Rajtar-Salwa, 2013 .

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry

M. Wełnicki, J. Bednarski, B. Wożakowska-Kapłon, 2020, Journal of clinical medicine.

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry

M. Wełnicki, J. Bednarski, B. Wożakowska-Kapłon, 2021, Journal of clinical medicine.

Apical pseudoaneurysm after transapical transcatheter aortic valve implantation.

D. Sorysz, D. Dudek, A. Dziewierz, 2017, Polish archives of internal medicine.

O R I G I N A L A R T I C L E Knowledge and prevalence of risk factors for coronary artery disease in patients after the first and repeated percutaneous coronary intervention

Z. Siudak, D. Dudek, A. Dziewierz, 2020 .

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry

M. Wełnicki, P. Krzesiński, J. Bednarski, 2021, Journal of clinical medicine.

Associaton of elevated troponin levels with increased heart rate and higher frequency of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.

P. Petkow Dimitrow, R. Rajtar-Salwa, Rafał Hładij, 2017, Polish archives of internal medicine.

Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation

W. Wojciechowska, M. Rajzer, A. Undas, 2023, Translational stroke research.

"Heart without smoke" educational campaign - the role of patient education in secondary prevention of cardiovascular disease.

Z. Siudak, D. Dudek, J. Godlewski, 2018, Kardiologia polska.

Cardiac magnetic resonance imaging in a woman suspected of hypertrophic cardiomyopathy based on genotyping.

M. Urbańczyk, E. Wypasek, P. Petkow-Dimitrow, 2018, Polish archives of internal medicine.

Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry.

M. Wełnicki, P. Krzesiński, J. Bednarski, 2021, Cardiovascular diagnosis and therapy.

Prevalence of familial hypercholesterolemia in patients with acute coronary syndromes.

D. Dudek, A. Dziewierz, W. Zasada, 2019, Kardiologia polska.

Anatomic Variations of Renal Arteries as an Important Factor in the Effectiveness of Renal Denervation in Resistant Hypertension

S. Bartuś, P. Petkow-Dimitrow, R. Rajtar-Salwa, 2023, Journal of cardiovascular development and disease.

Lipid-Lowering Therapy after Acute Coronary Syndrome in Outpatient Practice—How to Achieve Goal

Beata Bobrowska, S. Bartuś, P. Petkow-Dimitrow, 2023, Journal of clinical medicine.

Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels

P. Dobrowolski, T. Osadnik, Beata Bobrowska, 2024, Archives of medical science : AMS.

Exercise stress test methodology and safety in hypertrophic cardiomyopathy

T. Tokarek, P. Dimitrow, R. Rajtar-Salwa, 2020, European journal of preventive cardiology.

Hypertrophic Cardiomyopathy: The Time-Synchronized Relationship between Ischemia and Left Ventricular Dysfunction Assessed by Highly Sensitive Troponin I and NT-proBNP

A. Dziewierz, P. Dimitrow, R. Rajtar-Salwa, 2019, Disease markers.

Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014

P. Dimitrow, R. Rajtar-Salwa, Rafał Hładij, 2017, Disease markers.

Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy

A. Dziewierz, P. Petkow-Dimitrow, R. Rajtar-Salwa, 2020, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.